Botox Maker Sues Over Off-Label Rules, Citing Free Speech

In an attack on the regulation of drug marketing, the makers of the antiwrinkle shot Botox have filed a free-speech lawsuit against the federal government.

In the complaint, filed Thursday in federal court in Washington, the specialty pharmaceutical company Allergan charged that restrictions on promoting unapproved uses of Botox for medical conditions like spasticity violate the company’s First Amendment rights to speak freely and truthfully with doctors about its drug products.

Read full story via NYTimes.com.

Short URL: http://www.plasticsurgeonsnews.com/?p=413

Posted by admin on Oct 2 2009. Filed under Injectables. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry